NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Solid Biosciences Inc. Common Stock Share Price Chart

O H L

Solid Biosciences Inc. Common Stock Performance Overview

Days Range
$8.73Low
$8.84High

Markets Today

Previous Close$8.87
Open$8.83
Volume143,316
Day's Range$8.73 - $8.84
52W Range$3.79 - $11.45
Market Cap$935.00 M

Historical Performance

1M Returns-2.31
3M Returns+6.48
6M Returns+24.58
1Y Returns+63.05
5Y Returns-78.88
10Y ReturnsNA

Solid Biosciences Inc. Common Stock Fundamentals

Market Cap$935.00 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-1.10
EPS TTM$-1.91
Quarterly Earnings Growth YOYN/A
PB Ratio2.45
EBITDA$-177.57 M
Profit MarginN/A
Market Cap$935.00 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-1.10
EPS TTM$-1.91
Quarterly Earnings Growth YOYN/A
PB Ratio2.45
EBITDA$-177.57 M
Profit MarginN/A

Solid Biosciences Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$40.05 M-$41.69 M-$48.06 M-$49.40 M-$57.31 M-$57.38 M
EBITDA -$39.65 M-$41.31 M-$47.68 M-$48.94 M-$56.91 M-$56.99 M
Interest Expense -$68.00 K-$60.00 K$336.00 K-$5.00 K$0$0
Depreciation $407.00 K$386.00 K$376.00 K$467.00 K$395.00 K$391.00 K
Income Before Tax -$39.28 M-$39.48 M-$45.78 M-$49.79 M-$56.74 M-$54.80 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$39.28 M-$39.48 M-$45.78 M-$49.79 M-$56.74 M-$54.80 M
Net Profit Margin ------

Solid Biosciences Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $77.00 K$78.00 K$78.00 K$79.00 K$98.00 K$105.00 K
Reserve & Surplus -$822.73 M-$862.25 M-$907.94 M-$957.72 M-$1.01 B-$1.07 B
Non-Current Liabilities $20.66 M$20.16 M$19.62 M$19.06 M$18.48 M$17.92 M
Current Liabilities $28.78 M$29.85 M$36.34 M$33.47 M$30.28 M$28.58 M
Total Liabilities $49.44 M$50.00 M$55.97 M$52.53 M$48.76 M$46.51 M
Fixed Assets $4.48 M$4.32 M$4.36 M$4.17 M$3.91 M$3.96 M
Current Assets $313.41 M$278.64 M$244.85 M$205.46 M$396.79 M$395.11 M
Total Assets $343.90 M$308.29 M$273.91 M$232.54 M$422.89 M$420.58 M

Solid Biosciences Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$39.28 M-$39.48 M-$45.78 M-$49.79 M-$56.74 M-$54.80 M
Operating Cash Flow -$31.85 M-$37.41 M-$33.47 M-$53.55 M-$47.23 M-$52.59 M
Investing Cash Flow -$27.46 M-$32.73 M-$45.27 M$47.01 M$44.76 M-$133.59 M
Financing Cash Flow $189.73 M-$1.60 M$1.18 M$5.14 M$239.03 M$48.47 M
Change in Cash $130.41 M-$71.75 M-$77.57 M-$1.40 M$236.56 M-$137.71 M

Solid Biosciences Inc. Common Stock Return Calculator

The Solid Biosciences Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,071
Invested Amount$10,000
Est. Returns$-7,929
Invest in USA Stock Today

About Solid Biosciences Inc. Common Stock

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

FAQs

Solid Biosciences Inc. Common Stock (SLDB) share price as of September 18, 2026 is $8.70. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Solid Biosciences Inc. Common Stock (SLDB) Share by opening an international trading account with Angel One.
Purchasing Solid Biosciences Inc. Common Stock (SLDB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Solid Biosciences Inc. Common Stock (SLDB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Solid Biosciences Inc. Common Stock (SLDB) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Solid Biosciences Inc. Common Stock on September 18, 2026, is $935.00 M.
Solid Biosciences Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Solid Biosciences Inc. Common Stock (SLDB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91